Our impact

Read case studies where we have partnered with clients in each of our four key mission areas.

Price right

How a deep-dive analysis of key analogues allowed for the development of focused recommendations to optimize long-term success for an advanced oncology product facing multiple indication expansions

How focusing on the operational elements of pricing strategy supported in-country teams to strengthen their approach to pricing incremental innovation

How the development of an international reference pricing model, supported by a deep understanding of market access dynamics, has supported launch sequencing of two specialty products

How a deep understanding of pricing mechanisms in Japan enabled the formulation of a robust price estimate for a novel radiopharmaceutical

How an innovative pricing calculator enabled the identification of key value drivers and compelling value metrics to support asset strategy

How a semi-quantitative assessment of achievable pricing, combined with extensive input from global & affiliate colleagues, enabled the refinement of the global pricing strategy leading up to launch

How a DELPHI survey informed the key inputs of a health economic model to support the launch of a breakthrough specialty product

How an interactive gene therapy budget impact model produced greater internal understanding and facilitated communication with external stakeholders

How creating a unified vision and comprehensive framework for Real-World Evidence (RWE) supported seamless execution of RWE projects

How synthesizing multiple perspectives has enabled the refinement of the market access strategy for four novel cell therapies

How i-vbp® helped a specialty company pilot a new way to assess the value of targets for acquisition in multiple rare diseases CNS diseases

How synthesizing multiple perspectives has enabled the refinement of the clinical development plan and market access strategy for a novel drug in PD

How developing and testing of a value narrative with payers formed the foundation for a strong early market access strategy

How a thorough analysis of potential access scenarios allowed to successfully launch a new indication of a product

How i-vbp enabled the identification of the disease attractiveness and key value metrics to support a product’s indication prioritization strategy

How developing an early payer value story and value messages supported a differentiated offer within neurology, covering multiple possible scenarios at global and regional levels

How expert insights have helped gain a better understanding on the upcoming Joint Clinical Assessment in the EU and its challenges

How developing a framework for Value Based Partnerships provided a platform for affiliates to explore how different tactics could be used to accelerate access

How partnering with local experts helped define wave 3 of launch countries for our client’s geographical expansion

How engaging with affiliates allowed for the development of a fully adaptable budget impact model to support successful launches across all Wave 1 markets

What we do

Tailored solutions for today’s toughest market access challenges, helping you to prepare for tomorrow’s value-based healthcare.

Who we are

We are on a mission to help you to create superior value and optimise healthcare worldwide

Get started with Inbeeo and realise the true value of your assets.

Menu

Our impact

Menu

Our impact

Price right

How a deep-dive analysis of key analogues allowed for the development of focused recommendations to optimize long-term success for an advanced oncology product facing multiple indication expansions

How focusing on the operational elements of pricing strategy supported in-country teams to strengthen their approach to pricing incremental innovation

How the development of an international reference pricing model, supported by a deep understanding of market access dynamics, has supported launch sequencing of two specialty products

How a deep understanding of pricing mechanisms in Japan enabled the formulation of a robust price estimate for a novel radiopharmaceutical

How an innovative pricing calculator enabled the identification of key value drivers and compelling value metrics to support asset strategy

How a semi-quantitative assessment of achievable pricing, combined with extensive input from global & affiliate colleagues, enabled the refinement of the global pricing strategy leading up to launch

Gain the deepest understanding of the data

How a DELPHI survey informed the key inputs of a health economic model to support the launch of a breakthrough specialty product

How an interactive gene therapy budget impact model produced greater internal understanding and facilitated communication with external stakeholders

How creating a unified vision and comprehensive framework for Real-World Evidence (RWE) supported seamless execution of RWE projects

Define the right value strategies

How synthesizing multiple perspectives has enabled the refinement of the market access strategy for four novel cell therapies

How i-vbp® helped a specialty company pilot a new way to assess the value of targets for acquisition in multiple rare diseases CNS diseases

How synthesizing multiple perspectives has enabled the refinement of the clinical development plan and market access strategy for a novel drug in PD

How developing and testing of a value narrative with payers formed the foundation for a strong early market access strategy

How a thorough analysis of potential access scenarios allowed to successfully launch a new indication of a product

How i-vbp enabled the identification of the disease attractiveness and key value metrics to support a product’s indication prioritization strategy

How developing an early payer value story and value messages supported a differentiated offer within neurology, covering multiple possible scenarios at global and regional levels

Operationalize the value

How expert insights have helped gain a better understanding on the upcoming Joint Clinical Assessment in the EU and its challenges

How developing a framework for Value Based Partnerships provided a platform for affiliates to explore how different tactics could be used to accelerate access

How partnering with local experts helped define wave 3 of launch countries for our client’s geographical expansion

How engaging with affiliates allowed for the development of a fully adaptable budget impact model to support successful launches across all Wave 1 markets

What we do

Who we are

Get started with Inbeeo and realise the true value of your assets.

Quick Access

Hours & Info